{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T02:47:38Z","timestamp":1774925258969,"version":"3.50.1"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"vor","delay-in-days":1449,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T00:00:00Z","timestamp":1639699200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science KAKENHI","doi-asserted-by":"crossref","award":["18K15862"],"award-info":[{"award-number":["18K15862"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["18K15862"],"award-info":[{"award-number":["18K15862"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Urinary liver-type fatty acid-binding protein (L-FABP) is expressed in proximal tubular epithelial cells and excreted into the urine during tubular injury. We hypothesized that high urinary L-FABP is associated with poor prognosis in patients with acute heart failure (AHF).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>We analysed 623 patients (74 \u00b1 13 years old; 60.0% male patients) with AHF. Urinary L-FABP levels were measured at the time of admission and adjusted for the urinary creatinine concentration. The primary endpoint was all-cause mortality. The median value and interquartile range of urinary L-FABP levels were 6.66 and 3.37\u201321.1 \u03bcg\/gCr, respectively. Urinary L-FABP levels were significantly correlated with both beta-2 microglobulin and cystatin C levels; the correlation with the former was higher than that with the latter. During the follow-up of 631 (interquartile range: 387\u2013875) days, 142 deaths occurred. A high tertile of urinary L-FABP level was associated with high mortality; this association was retained after adjusting for other covariates (second tertile hazard ratio 1.40, P = 0.152 vs. first tertile; third tertile hazard ratio 1.94, P = 0.005 vs. first tertile).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Urinary L-FABP is more closely associated with tubular dysfunction than with glomerular dysfunction. Tubular dysfunction, which was evaluated based on urinary L-FABP levels, in patients with AHF is associated with all-cause mortality and is independent of pre-existing risk factors. L-FABP should be considered for use in the prognosis of AHF.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ehf2.13730","type":"journal-article","created":{"date-parts":[[2021,12,18]],"date-time":"2021-12-18T02:42:02Z","timestamp":1639795322000},"page":"442-449","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Urinary Liver-Type Fatty Acid-Binding Protein as a Prognostic Marker in Patients with Acute Heart Failure"],"prefix":"10.1093","volume":"9","author":[{"given":"Tsutomu","family":"Sunayama","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine , Tokyo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoichiro","family":"Yatsu","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine , Tokyo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2456-8525","authenticated-orcid":false,"given":"Yuya","family":"Matsue","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine , Tokyo ,","place":["Japan"]},{"name":"Cardiovascular Respiratory Sleep Medicine, Juntendo University Graduate School of Medicine , Tokyo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taishi","family":"Dotare","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine , Tokyo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daichi","family":"Maeda","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine , Tokyo ,","place":["Japan"]},{"name":"Department of Cardiology, Osaka Medical and Pharmaceutical University , Osaka ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayaki","family":"Ishiwata","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine , Tokyo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine , Tokyo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoko","family":"Suda","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine , Tokyo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takao","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine , Tokyo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaru","family":"Hiki","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine , Tokyo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takatoshi","family":"Kasai","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine , Tokyo ,","place":["Japan"]},{"name":"Cardiovascular Respiratory Sleep Medicine, Juntendo University Graduate School of Medicine , Tokyo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tohru","family":"Minamino","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine , Tokyo ,","place":["Japan"]},{"name":"Japan Agency for Medical Research and Development-Core Research for Evolutionary Medical Science and Technology (AMED-CREST), Japan Agency for Medical Research and Development , Tokyo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,12,17]]},"reference":[{"key":"2026012114182804200_ehf213730-bib-0001","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.amjcard.2019.06.025","article-title":"Trends in the management of acute heart failure requiring intensive care","volume":"124","author":"Shirakabe","year":"2019","journal-title":"Am J Cardiol"},{"key":"2026012114182804200_ehf213730-bib-0002","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/eurheartj\/eht386","article-title":"Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis","volume":"35","author":"Damman","year":"2014","journal-title":"Eur Heart J"},{"key":"2026012114182804200_ehf213730-bib-0003","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1007\/s00134-010-1887-4","article-title":"Neutrophil gelatinase-associated lipocalin in adult septic patients with and without acute kidney injury","volume":"36","author":"Martensson","year":"2010","journal-title":"Intensive Care Med"},{"key":"2026012114182804200_ehf213730-bib-0004","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1093\/eurheartj\/ehr190","article-title":"Clinical outcome of renal tubular damage in chronic heart failure","volume":"32","author":"Damman","year":"2011","journal-title":"Eur Heart J"},{"key":"2026012114182804200_ehf213730-bib-0005","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1365-2796.2011.02503.x","article-title":"The association between neutrophil gelatinase-associated lipocalin and clinical outcome in chronic heart failure: results from CORONA*","volume":"271","author":"Nymo","year":"2012","journal-title":"J Intern Med"},{"key":"2026012114182804200_ehf213730-bib-0006","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1093\/eurjhf\/hfr102","article-title":"Kidney injury molecule-1 and N-acetyl-beta-D-glucosaminidase in chronic heart failure: possible biomarkers of cardiorenal syndrome","volume":"13","author":"Jungbauer","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"2026012114182804200_ehf213730-bib-0007","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jjcc.2009.10.003","article-title":"Serum beta2-microglobulin concentration as a novel marker to distinguish levels of risk in acute heart failure patients","volume":"55","author":"Kawai","year":"2010","journal-title":"J Cardiol"},{"key":"2026012114182804200_ehf213730-bib-0008","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.amjcard.2015.03.043","article-title":"Comparison of neutrophil gelatinase-associated lipocalin versus B-type natriuretic peptide and cystatin C to predict early acute kidney injury and outcome in patients with acute heart failure","volume":"116","author":"Palazzuoli","year":"2015","journal-title":"Am J Cardiol"},{"key":"2026012114182804200_ehf213730-bib-0009","first-page":"429","article-title":"Elevated admission urinary N-acetyl-beta-D-glucosamidase level is associated with worse long-term clinical outcomes in patients with acute heart failure","volume":"9","author":"Funabashi","year":"2020","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"2026012114182804200_ehf213730-bib-0010","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1681\/ASN.2007010097","article-title":"Renal L-type fatty acid\u2013binding protein in acute ischemic injury","volume":"18","author":"Yamamoto","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"2026012114182804200_ehf213730-bib-0011","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.2215\/CJN.10971012","article-title":"Performance of kidney injury molecule-1 and liver fatty acid-binding protein and combined biomarkers of AKI after cardiac surgery","volume":"8","author":"Parikh","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026012114182804200_ehf213730-bib-0012","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1097\/CCM.0b013e3181eedac0","article-title":"Urinary L-type fatty acid-binding protein as a new biomarker of sepsis complicated with acute kidney injury","volume":"38","author":"Doi","year":"2010","journal-title":"Crit Care Med"},{"key":"2026012114182804200_ehf213730-bib-0013","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1053\/j.ajkd.2012.10.016","article-title":"Performance of urinary liver-type fatty acid-binding protein in acute kidney injury: a meta-analysis","volume":"61","author":"Susantitaphong","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"2026012114182804200_ehf213730-bib-0014","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.cardfail.2018.07.003","article-title":"Increased urinary liver-type fatty acid-binding protein level predicts worsening renal function in patients with acute heart failure","volume":"24","author":"Okubo","year":"2018","journal-title":"J Card Fail"},{"key":"2026012114182804200_ehf213730-bib-0015","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1161\/01.CIR.88.1.107","article-title":"Survival after the onset of congestive heart failure in Framingham heart study subjects","volume":"88","author":"Ho","year":"1993","journal-title":"Circulation"},{"key":"2026012114182804200_ehf213730-bib-0016","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1161\/01.CIR.0000019121.91548.C2","article-title":"B-type natriuretic peptide levels: diagnostic and prognostic in congestive heart failure: what's next?","volume":"105","author":"Maisel","year":"2002","journal-title":"Circulation"},{"key":"2026012114182804200_ehf213730-bib-0017","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","article-title":"2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"18","author":"Ponikowski","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2026012114182804200_ehf213730-bib-0018","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.cca.2013.05.020","article-title":"Urinary liver type fatty acid binding protein in diabetic nephropathy","volume":"424","author":"Kamijo-Ikemori","year":"2013","journal-title":"Clin Chim Acta"},{"key":"2026012114182804200_ehf213730-bib-0019","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/0471722146","volume-title":"Applied Logistic Regression","author":"Hosmer","year":"2000"},{"key":"2026012114182804200_ehf213730-bib-0020","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R","article-title":"Multiple imputation of missing blood pressure covariates in survival analysis","volume":"18","author":"van Buuren","year":"1999","journal-title":"Stat Med"},{"key":"2026012114182804200_ehf213730-bib-0021","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1093\/biomet\/86.4.948","article-title":"Miscellanea. Small-sample degrees of freedom with multiple imputation","volume":"86","author":"Barnard","year":"1999","journal-title":"Biometrika"},{"key":"2026012114182804200_ehf213730-bib-0022","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"key":"2026012114182804200_ehf213730-bib-0023","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/sim.4085","article-title":"Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers","volume":"30","author":"Pencina","year":"2011","journal-title":"Stat Med"},{"key":"2026012114182804200_ehf213730-bib-0024","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1136\/hrt.2010.194878","article-title":"Tubular damage in chronic systolic heart failure is associated with reduced survival independent of glomerular filtration rate","volume":"96","author":"Damman","year":"2010","journal-title":"Heart"},{"key":"2026012114182804200_ehf213730-bib-0025","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/nep.12632","article-title":"N-acteyl-ss-D-glucosaminidase and kidney injury molecule-1: new predictors for long-term progression of chronic kidney disease in patients with heart failure","volume":"21","author":"Jungbauer","year":"2016","journal-title":"Nephrology (Carlton)"},{"key":"2026012114182804200_ehf213730-bib-0026","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1161\/CIRCHEARTFAILURE.112.000089","article-title":"The impact of renal tubular damage, as assessed by urinary beta2-microglobulin-creatinine ratio, on cardiac prognosis in patients with chronic heart failure","volume":"6","author":"Otaki","year":"2013","journal-title":"Circ Heart Fail"},{"key":"2026012114182804200_ehf213730-bib-0027","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.jacc.2016.06.055","article-title":"Neutrophil gelatinase-associated lipocalin for acute kidney injury during acute heart failure hospitalizations: the AKINESIS study","volume":"68","author":"Maisel","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2026012114182804200_ehf213730-bib-0028","doi-asserted-by":"crossref","first-page":"F669","DOI":"10.1152\/ajprenal.90513.2008","article-title":"Urinary fatty acid-binding protein 1: an early predictive biomarker of kidney injury","volume":"296","author":"Noiri","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"2026012114182804200_ehf213730-bib-0029","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/apha.12764","article-title":"Biomarkers in acute kidney injury\u2014pathophysiological basis and clinical performance","volume":"219","author":"Schrezenmeier","year":"2017","journal-title":"Acta Physiol (Oxf)"},{"key":"2026012114182804200_ehf213730-bib-0030","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1093\/eurheartj\/ehv588","article-title":"Biomarkers of renal injury and function: diagnostic, prognostic and therapeutic implications in heart failure","volume":"37","author":"van Veldhuisen","year":"2016","journal-title":"Eur Heart J"},{"key":"2026012114182804200_ehf213730-bib-0031","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1293\/tox.2014-0039","article-title":"Comparison of changes in urinary and blood levels of biomarkers associated with proximal tubular injury in rat models","volume":"28","author":"Kuwata","year":"2015","journal-title":"J Toxicol Pathol"},{"key":"2026012114182804200_ehf213730-bib-0032","doi-asserted-by":"crossref","first-page":"691","DOI":"10.2337\/dc10-1392","article-title":"Clinical significance of urinary liver-type fatty acid-binding protein in diabetic nephropathy of type 2 diabetic patients","volume":"34","author":"Kamijo-Ikemori","year":"2011","journal-title":"Diabetes Care"},{"key":"2026012114182804200_ehf213730-bib-0033","first-page":"545","article-title":"Urinary L-type fatty acid-binding protein as a new renal biomarker in critical care","volume":"16","author":"Doi","year":"2010","journal-title":"Curr Opin Crit Care"},{"key":"2026012114182804200_ehf213730-bib-0034","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s13054-018-2120-z","article-title":"Predicting acute kidney injury using urinary liver-type fatty-acid binding protein and serum N-terminal pro-B-type natriuretic peptide levels in patients treated at medical cardiac intensive care units","volume":"22","author":"Naruse","year":"2018","journal-title":"Crit Care"},{"key":"2026012114182804200_ehf213730-bib-0035","first-page":"1195","article-title":"Beneficial effects of olmesartan and temocapril on urinary liver-type fatty acid-binding protein levels in normotensive patients with immunoglobin A nephropathy","volume":"20","author":"Nakamura","year":"2007","journal-title":"Am J Hypertens"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ehf2.13730","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ehf2.13730","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/9\/1\/442\/65374933\/eschf_9_1_442.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/9\/1\/442\/65374933\/eschf_9_1_442.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T19:21:53Z","timestamp":1769023313000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/9\/1\/442\/8326355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,17]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12,17]]},"published-print":{"date-parts":[[2022,2,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.13730","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,2]]},"published":{"date-parts":[[2021,12,17]]},"assertion":[{"value":"2021-06-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-10","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}